nodes	percent_of_prediction	percent_of_DWPC	metapath
Dronedarone—ALB—lung cancer	0.133	0.512	CbGaD
Dronedarone—ABCB1—lung cancer	0.126	0.488	CbGaD
Dronedarone—ALB—Gefitinib—lung cancer	0.0348	0.0946	CbGbCtD
Dronedarone—ALB—Erlotinib—lung cancer	0.0206	0.0559	CbGbCtD
Dronedarone—ABCB1—Topotecan—lung cancer	0.0199	0.0541	CbGbCtD
Dronedarone—ALB—Irinotecan—lung cancer	0.0186	0.0505	CbGbCtD
Dronedarone—ABCB1—Gefitinib—lung cancer	0.0182	0.0495	CbGbCtD
Dronedarone—CYP2D6—Gefitinib—lung cancer	0.0171	0.0466	CbGbCtD
Dronedarone—ABCB1—Vinorelbine—lung cancer	0.014	0.0381	CbGbCtD
Dronedarone—CYP2D6—Vinorelbine—lung cancer	0.0132	0.0359	CbGbCtD
Dronedarone—CYP3A4—Topotecan—lung cancer	0.0119	0.0324	CbGbCtD
Dronedarone—ABCB1—Crizotinib—lung cancer	0.0111	0.0303	CbGbCtD
Dronedarone—CYP3A4—Gefitinib—lung cancer	0.0109	0.0296	CbGbCtD
Dronedarone—ABCB1—Gemcitabine—lung cancer	0.0109	0.0296	CbGbCtD
Dronedarone—ABCB1—Erlotinib—lung cancer	0.0108	0.0293	CbGbCtD
Dronedarone—CYP3A4—Teniposide—lung cancer	0.0106	0.0288	CbGbCtD
Dronedarone—CYP2D6—Erlotinib—lung cancer	0.0101	0.0276	CbGbCtD
Dronedarone—ABCB1—Paclitaxel—lung cancer	0.00984	0.0268	CbGbCtD
Dronedarone—ALB—Methotrexate—lung cancer	0.00982	0.0267	CbGbCtD
Dronedarone—ABCB1—Irinotecan—lung cancer	0.00971	0.0264	CbGbCtD
Dronedarone—ABCB1—Vinblastine—lung cancer	0.00863	0.0235	CbGbCtD
Dronedarone—CYP3A4—Vinorelbine—lung cancer	0.00839	0.0228	CbGbCtD
Dronedarone—CYP2D6—Vinblastine—lung cancer	0.00814	0.0221	CbGbCtD
Dronedarone—ABCB1—Cisplatin—lung cancer	0.00792	0.0215	CbGbCtD
Dronedarone—ABCB1—Etoposide—lung cancer	0.00778	0.0212	CbGbCtD
Dronedarone—ABCB1—Docetaxel—lung cancer	0.00712	0.0194	CbGbCtD
Dronedarone—CYP3A4—Crizotinib—lung cancer	0.00668	0.0182	CbGbCtD
Dronedarone—CYP3A4—Erlotinib—lung cancer	0.00644	0.0175	CbGbCtD
Dronedarone—CYP3A4—Paclitaxel—lung cancer	0.0059	0.016	CbGbCtD
Dronedarone—CYP3A4—Irinotecan—lung cancer	0.00582	0.0158	CbGbCtD
Dronedarone—ABCB1—Doxorubicin—lung cancer	0.00531	0.0144	CbGbCtD
Dronedarone—CYP3A4—Vinblastine—lung cancer	0.00517	0.0141	CbGbCtD
Dronedarone—ABCB1—Methotrexate—lung cancer	0.00514	0.014	CbGbCtD
Dronedarone—CYP2D6—Doxorubicin—lung cancer	0.005	0.0136	CbGbCtD
Dronedarone—CYP3A4—Etoposide—lung cancer	0.00466	0.0127	CbGbCtD
Dronedarone—CYP3A4—Docetaxel—lung cancer	0.00426	0.0116	CbGbCtD
Dronedarone—HCN4—cardiac atrium—lung cancer	0.00362	0.0934	CbGeAlD
Dronedarone—KCNK2—mammary gland—lung cancer	0.00346	0.0893	CbGeAlD
Dronedarone—CYP3A4—Doxorubicin—lung cancer	0.00318	0.00865	CbGbCtD
Dronedarone—CACNB3—mammary gland—lung cancer	0.00299	0.0771	CbGeAlD
Dronedarone—HCN2—cardiac atrium—lung cancer	0.00275	0.0708	CbGeAlD
Dronedarone—CACNB3—bronchus—lung cancer	0.00164	0.0423	CbGeAlD
Dronedarone—CACNB3—trachea—lung cancer	0.00147	0.038	CbGeAlD
Dronedarone—CACNB4—lung—lung cancer	0.00138	0.0356	CbGeAlD
Dronedarone—ALB—mammary gland—lung cancer	0.00126	0.0324	CbGeAlD
Dronedarone—CACNA1C—respiratory system—lung cancer	0.00108	0.0279	CbGeAlD
Dronedarone—CACNB3—lung—lung cancer	0.00106	0.0273	CbGeAlD
Dronedarone—ADRA1D—epithelium—lung cancer	0.00097	0.025	CbGeAlD
Dronedarone—CACNB2—cardiac atrium—lung cancer	0.00093	0.024	CbGeAlD
Dronedarone—Amiodarone—CYP2A6—lung cancer	0.000922	0.482	CrCbGaD
Dronedarone—KCNK2—lymph node—lung cancer	0.000838	0.0216	CbGeAlD
Dronedarone—CACNA1D—cardiac atrium—lung cancer	0.000813	0.021	CbGeAlD
Dronedarone—CACNB1—lymph node—lung cancer	0.000755	0.0195	CbGeAlD
Dronedarone—CACNA1C—cardiac atrium—lung cancer	0.00075	0.0193	CbGeAlD
Dronedarone—CACNB3—lymph node—lung cancer	0.000724	0.0187	CbGeAlD
Dronedarone—CACNB2—lung—lung cancer	0.000711	0.0183	CbGeAlD
Dronedarone—ADRB1—bronchus—lung cancer	0.000694	0.0179	CbGeAlD
Dronedarone—SCN1A—lung—lung cancer	0.000691	0.0178	CbGeAlD
Dronedarone—Amiodarone—CYP1A1—lung cancer	0.000646	0.338	CrCbGaD
Dronedarone—CACNA1D—lung—lung cancer	0.000622	0.016	CbGeAlD
Dronedarone—ADRB1—cardiac atrium—lung cancer	0.000585	0.0151	CbGeAlD
Dronedarone—CACNA1C—lung—lung cancer	0.000574	0.0148	CbGeAlD
Dronedarone—ADRA1A—epithelium—lung cancer	0.000557	0.0144	CbGeAlD
Dronedarone—ADRA2C—bronchus—lung cancer	0.000523	0.0135	CbGeAlD
Dronedarone—CACNB2—lymph node—lung cancer	0.000486	0.0125	CbGeAlD
Dronedarone—ADRA2C—trachea—lung cancer	0.00047	0.0121	CbGeAlD
Dronedarone—ADRB1—lung—lung cancer	0.000448	0.0115	CbGeAlD
Dronedarone—KCNH2—cardiac atrium—lung cancer	0.000447	0.0115	CbGeAlD
Dronedarone—ADRA2C—cardiac atrium—lung cancer	0.000441	0.0114	CbGeAlD
Dronedarone—CACNA1D—lymph node—lung cancer	0.000425	0.011	CbGeAlD
Dronedarone—ADRA2A—bronchus—lung cancer	0.000417	0.0108	CbGeAlD
Dronedarone—CACNA1C—lymph node—lung cancer	0.000393	0.0101	CbGeAlD
Dronedarone—Erythema—Vinorelbine—lung cancer	0.000386	0.00223	CcSEcCtD
Dronedarone—Rash—Gefitinib—lung cancer	0.000384	0.00222	CcSEcCtD
Dronedarone—Dermatitis—Gefitinib—lung cancer	0.000384	0.00221	CcSEcCtD
Dronedarone—Unspecified disorder of skin and subcutaneous tissue—Topotecan—lung cancer	0.000382	0.0022	CcSEcCtD
Dronedarone—Unspecified disorder of skin and subcutaneous tissue—Erlotinib—lung cancer	0.000378	0.00218	CcSEcCtD
Dronedarone—KCNH2—bone marrow—lung cancer	0.000377	0.00973	CbGeAlD
Dronedarone—Hepatobiliary disease—Gemcitabine—lung cancer	0.000375	0.00216	CcSEcCtD
Dronedarone—ADRA2A—trachea—lung cancer	0.000375	0.00966	CbGeAlD
Dronedarone—Cardiac failure—Docetaxel—lung cancer	0.000375	0.00216	CcSEcCtD
Dronedarone—Liver injury—Doxorubicin—lung cancer	0.000374	0.00215	CcSEcCtD
Dronedarone—Bradycardia—Irinotecan—lung cancer	0.000372	0.00215	CcSEcCtD
Dronedarone—Vasculitis—Methotrexate—lung cancer	0.000372	0.00214	CcSEcCtD
Dronedarone—Anaphylactic shock—Topotecan—lung cancer	0.000368	0.00212	CcSEcCtD
Dronedarone—Nausea—Pemetrexed—lung cancer	0.000365	0.0021	CcSEcCtD
Dronedarone—Nausea—Gefitinib—lung cancer	0.000362	0.00209	CcSEcCtD
Dronedarone—Nervous system disorder—Topotecan—lung cancer	0.000361	0.00208	CcSEcCtD
Dronedarone—Skin disorder—Topotecan—lung cancer	0.000358	0.00206	CcSEcCtD
Dronedarone—Nervous system disorder—Erlotinib—lung cancer	0.000358	0.00206	CcSEcCtD
Dronedarone—Asthenia—Teniposide—lung cancer	0.000357	0.00206	CcSEcCtD
Dronedarone—Skin disorder—Erlotinib—lung cancer	0.000354	0.00204	CcSEcCtD
Dronedarone—Angioedema—Vinorelbine—lung cancer	0.000353	0.00203	CcSEcCtD
Dronedarone—ADRA2A—cardiac atrium—lung cancer	0.000352	0.00907	CbGeAlD
Dronedarone—Pruritus—Teniposide—lung cancer	0.000352	0.00203	CcSEcCtD
Dronedarone—Hepatobiliary disease—Cisplatin—lung cancer	0.00035	0.00202	CcSEcCtD
Dronedarone—Amiodarone—ABCB1—lung cancer	0.000343	0.18	CrCbGaD
Dronedarone—Pneumonia—Etoposide—lung cancer	0.000341	0.00197	CcSEcCtD
Dronedarone—Photosensitivity reaction—Paclitaxel—lung cancer	0.00034	0.00196	CcSEcCtD
Dronedarone—Diarrhoea—Teniposide—lung cancer	0.00034	0.00196	CcSEcCtD
Dronedarone—Cardiac disorder—Irinotecan—lung cancer	0.00034	0.00196	CcSEcCtD
Dronedarone—Bradycardia—Cisplatin—lung cancer	0.000338	0.00195	CcSEcCtD
Dronedarone—ADRA2C—lung—lung cancer	0.000337	0.0087	CbGeAlD
Dronedarone—Pneumonia—Paclitaxel—lung cancer	0.000334	0.00193	CcSEcCtD
Dronedarone—Angiopathy—Irinotecan—lung cancer	0.000332	0.00191	CcSEcCtD
Dronedarone—Cardiac disorder—Gemcitabine—lung cancer	0.000331	0.00191	CcSEcCtD
Dronedarone—Immune system disorder—Irinotecan—lung cancer	0.00033	0.00191	CcSEcCtD
Dronedarone—Mediastinal disorder—Irinotecan—lung cancer	0.00033	0.0019	CcSEcCtD
Dronedarone—Unspecified disorder of skin and subcutaneous tissue—Vinorelbine—lung cancer	0.000327	0.00188	CcSEcCtD
Dronedarone—Dyspepsia—Topotecan—lung cancer	0.000324	0.00187	CcSEcCtD
Dronedarone—Angiopathy—Gemcitabine—lung cancer	0.000323	0.00186	CcSEcCtD
Dronedarone—Immune system disorder—Gemcitabine—lung cancer	0.000322	0.00186	CcSEcCtD
Dronedarone—Mediastinal disorder—Gemcitabine—lung cancer	0.000321	0.00185	CcSEcCtD
Dronedarone—Dyspepsia—Erlotinib—lung cancer	0.000321	0.00185	CcSEcCtD
Dronedarone—Hepatobiliary disease—Etoposide—lung cancer	0.000321	0.00185	CcSEcCtD
Dronedarone—Gastrointestinal disorder—Topotecan—lung cancer	0.000318	0.00183	CcSEcCtD
Dronedarone—Fatigue—Topotecan—lung cancer	0.000318	0.00183	CcSEcCtD
Dronedarone—Vomiting—Teniposide—lung cancer	0.000316	0.00182	CcSEcCtD
Dronedarone—Anaphylactic shock—Vinorelbine—lung cancer	0.000315	0.00182	CcSEcCtD
Dronedarone—Gastrointestinal disorder—Erlotinib—lung cancer	0.000315	0.00181	CcSEcCtD
Dronedarone—Hepatobiliary disease—Paclitaxel—lung cancer	0.000314	0.00181	CcSEcCtD
Dronedarone—Fatigue—Erlotinib—lung cancer	0.000314	0.00181	CcSEcCtD
Dronedarone—Rash—Teniposide—lung cancer	0.000313	0.00181	CcSEcCtD
Dronedarone—Dermatitis—Teniposide—lung cancer	0.000313	0.00181	CcSEcCtD
Dronedarone—Erythema—Gemcitabine—lung cancer	0.00031	0.00179	CcSEcCtD
Dronedarone—Gastrointestinal pain—Vinblastine—lung cancer	0.00031	0.00179	CcSEcCtD
Dronedarone—Nervous system disorder—Vinorelbine—lung cancer	0.000309	0.00178	CcSEcCtD
Dronedarone—Cardiac disorder—Cisplatin—lung cancer	0.000308	0.00178	CcSEcCtD
Dronedarone—Skin disorder—Vinorelbine—lung cancer	0.000306	0.00177	CcSEcCtD
Dronedarone—ALB—lymph node—lung cancer	0.000304	0.00785	CbGeAlD
Dronedarone—Bradycardia—Paclitaxel—lung cancer	0.000304	0.00175	CcSEcCtD
Dronedarone—Gastrointestinal pain—Topotecan—lung cancer	0.000301	0.00174	CcSEcCtD
Dronedarone—Immune system disorder—Cisplatin—lung cancer	0.0003	0.00173	CcSEcCtD
Dronedarone—Abdominal pain—Vinblastine—lung cancer	0.0003	0.00173	CcSEcCtD
Dronedarone—Mediastinal disorder—Cisplatin—lung cancer	0.000299	0.00173	CcSEcCtD
Dronedarone—Gastrointestinal pain—Erlotinib—lung cancer	0.000298	0.00172	CcSEcCtD
Dronedarone—Nausea—Teniposide—lung cancer	0.000295	0.0017	CcSEcCtD
Dronedarone—Abdominal pain—Topotecan—lung cancer	0.000291	0.00168	CcSEcCtD
Dronedarone—Erythema—Cisplatin—lung cancer	0.000289	0.00167	CcSEcCtD
Dronedarone—Abdominal pain—Erlotinib—lung cancer	0.000288	0.00166	CcSEcCtD
Dronedarone—Pneumonia—Docetaxel—lung cancer	0.000283	0.00163	CcSEcCtD
Dronedarone—ABCB1—respiratory system—lung cancer	0.000283	0.00728	CbGeAlD
Dronedarone—Cardiac disorder—Etoposide—lung cancer	0.000282	0.00163	CcSEcCtD
Dronedarone—Cardiac disorder—Paclitaxel—lung cancer	0.000277	0.0016	CcSEcCtD
Dronedarone—Angiopathy—Etoposide—lung cancer	0.000276	0.00159	CcSEcCtD
Dronedarone—Immune system disorder—Etoposide—lung cancer	0.000275	0.00158	CcSEcCtD
Dronedarone—Mediastinal disorder—Etoposide—lung cancer	0.000274	0.00158	CcSEcCtD
Dronedarone—Asthenia—Vinblastine—lung cancer	0.000272	0.00157	CcSEcCtD
Dronedarone—Gastrointestinal disorder—Vinorelbine—lung cancer	0.000272	0.00157	CcSEcCtD
Dronedarone—Fatigue—Vinorelbine—lung cancer	0.000272	0.00157	CcSEcCtD
Dronedarone—Angiopathy—Paclitaxel—lung cancer	0.000271	0.00156	CcSEcCtD
Dronedarone—Immune system disorder—Paclitaxel—lung cancer	0.00027	0.00155	CcSEcCtD
Dronedarone—ADRA2A—lung—lung cancer	0.000269	0.00694	CbGeAlD
Dronedarone—Mediastinal disorder—Paclitaxel—lung cancer	0.000269	0.00155	CcSEcCtD
Dronedarone—Hepatobiliary disease—Docetaxel—lung cancer	0.000266	0.00154	CcSEcCtD
Dronedarone—Asthenia—Topotecan—lung cancer	0.000264	0.00152	CcSEcCtD
Dronedarone—Unspecified disorder of skin and subcutaneous tissue—Gemcitabine—lung cancer	0.000262	0.00151	CcSEcCtD
Dronedarone—Asthenia—Erlotinib—lung cancer	0.000262	0.00151	CcSEcCtD
Dronedarone—Pruritus—Topotecan—lung cancer	0.000261	0.0015	CcSEcCtD
Dronedarone—Anaphylactic shock—Irinotecan—lung cancer	0.00026	0.0015	CcSEcCtD
Dronedarone—Erythema—Paclitaxel—lung cancer	0.00026	0.0015	CcSEcCtD
Dronedarone—Diarrhoea—Vinblastine—lung cancer	0.00026	0.0015	CcSEcCtD
Dronedarone—Dysgeusia—Etoposide—lung cancer	0.000259	0.0015	CcSEcCtD
Dronedarone—Pruritus—Erlotinib—lung cancer	0.000258	0.00149	CcSEcCtD
Dronedarone—Gastrointestinal pain—Vinorelbine—lung cancer	0.000258	0.00149	CcSEcCtD
Dronedarone—Nervous system disorder—Irinotecan—lung cancer	0.000255	0.00147	CcSEcCtD
Dronedarone—Dysgeusia—Paclitaxel—lung cancer	0.000254	0.00147	CcSEcCtD
Dronedarone—Eczema—Doxorubicin—lung cancer	0.000254	0.00146	CcSEcCtD
Dronedarone—Anaphylactic shock—Gemcitabine—lung cancer	0.000253	0.00146	CcSEcCtD
Dronedarone—Diarrhoea—Topotecan—lung cancer	0.000252	0.00145	CcSEcCtD
Dronedarone—Cardiac failure congestive—Doxorubicin—lung cancer	0.000252	0.00145	CcSEcCtD
Dronedarone—Diarrhoea—Erlotinib—lung cancer	0.000249	0.00144	CcSEcCtD
Dronedarone—Abdominal pain—Vinorelbine—lung cancer	0.000249	0.00144	CcSEcCtD
Dronedarone—Nervous system disorder—Gemcitabine—lung cancer	0.000248	0.00143	CcSEcCtD
Dronedarone—Skin disorder—Gemcitabine—lung cancer	0.000246	0.00142	CcSEcCtD
Dronedarone—Unspecified disorder of skin and subcutaneous tissue—Cisplatin—lung cancer	0.000245	0.00141	CcSEcCtD
Dronedarone—Vomiting—Vinblastine—lung cancer	0.000241	0.00139	CcSEcCtD
Dronedarone—Angioedema—Paclitaxel—lung cancer	0.000237	0.00137	CcSEcCtD
Dronedarone—ABCB1—epithelium—lung cancer	0.000236	0.00609	CbGeAlD
Dronedarone—Anaphylactic shock—Cisplatin—lung cancer	0.000236	0.00136	CcSEcCtD
Dronedarone—Cardiac disorder—Docetaxel—lung cancer	0.000235	0.00135	CcSEcCtD
Dronedarone—Vomiting—Topotecan—lung cancer	0.000234	0.00135	CcSEcCtD
Dronedarone—KCNH2—lymph node—lung cancer	0.000234	0.00603	CbGeAlD
Dronedarone—Cardiac failure—Doxorubicin—lung cancer	0.000234	0.00135	CcSEcCtD
Dronedarone—Rash—Topotecan—lung cancer	0.000232	0.00134	CcSEcCtD
Dronedarone—Dermatitis—Topotecan—lung cancer	0.000232	0.00134	CcSEcCtD
Dronedarone—Vomiting—Erlotinib—lung cancer	0.000232	0.00134	CcSEcCtD
Dronedarone—Nervous system disorder—Cisplatin—lung cancer	0.000231	0.00133	CcSEcCtD
Dronedarone—ADRA2C—lymph node—lung cancer	0.000231	0.00595	CbGeAlD
Dronedarone—Rash—Erlotinib—lung cancer	0.00023	0.00133	CcSEcCtD
Dronedarone—Dermatitis—Erlotinib—lung cancer	0.00023	0.00132	CcSEcCtD
Dronedarone—Angiopathy—Docetaxel—lung cancer	0.000229	0.00132	CcSEcCtD
Dronedarone—Skin disorder—Cisplatin—lung cancer	0.000229	0.00132	CcSEcCtD
Dronedarone—Dyspepsia—Irinotecan—lung cancer	0.000229	0.00132	CcSEcCtD
Dronedarone—Immune system disorder—Docetaxel—lung cancer	0.000228	0.00132	CcSEcCtD
Dronedarone—Mediastinal disorder—Docetaxel—lung cancer	0.000228	0.00131	CcSEcCtD
Dronedarone—Asthenia—Vinorelbine—lung cancer	0.000226	0.0013	CcSEcCtD
Dronedarone—Nausea—Vinblastine—lung cancer	0.000225	0.0013	CcSEcCtD
Dronedarone—Gastrointestinal disorder—Irinotecan—lung cancer	0.000224	0.00129	CcSEcCtD
Dronedarone—Fatigue—Irinotecan—lung cancer	0.000224	0.00129	CcSEcCtD
Dronedarone—Unspecified disorder of skin and subcutaneous tissue—Etoposide—lung cancer	0.000224	0.00129	CcSEcCtD
Dronedarone—Pruritus—Vinorelbine—lung cancer	0.000223	0.00129	CcSEcCtD
Dronedarone—Erythema—Docetaxel—lung cancer	0.00022	0.00127	CcSEcCtD
Dronedarone—Unspecified disorder of skin and subcutaneous tissue—Paclitaxel—lung cancer	0.00022	0.00127	CcSEcCtD
Dronedarone—Nausea—Topotecan—lung cancer	0.000219	0.00126	CcSEcCtD
Dronedarone—Gastrointestinal disorder—Gemcitabine—lung cancer	0.000219	0.00126	CcSEcCtD
Dronedarone—Fatigue—Gemcitabine—lung cancer	0.000218	0.00126	CcSEcCtD
Dronedarone—Nausea—Erlotinib—lung cancer	0.000217	0.00125	CcSEcCtD
Dronedarone—Anaphylactic shock—Etoposide—lung cancer	0.000216	0.00125	CcSEcCtD
Dronedarone—Diarrhoea—Vinorelbine—lung cancer	0.000216	0.00124	CcSEcCtD
Dronedarone—Dysgeusia—Docetaxel—lung cancer	0.000216	0.00124	CcSEcCtD
Dronedarone—Blood creatinine increased—Doxorubicin—lung cancer	0.000214	0.00123	CcSEcCtD
Dronedarone—Gastrointestinal pain—Irinotecan—lung cancer	0.000213	0.00123	CcSEcCtD
Dronedarone—Anaphylactic shock—Paclitaxel—lung cancer	0.000212	0.00122	CcSEcCtD
Dronedarone—Skin disorder—Etoposide—lung cancer	0.00021	0.00121	CcSEcCtD
Dronedarone—ABCB1—trachea—lung cancer	0.000209	0.00538	CbGeAlD
Dronedarone—Nervous system disorder—Paclitaxel—lung cancer	0.000208	0.0012	CcSEcCtD
Dronedarone—Photosensitivity reaction—Methotrexate—lung cancer	0.000208	0.0012	CcSEcCtD
Dronedarone—Hypokalaemia—Doxorubicin—lung cancer	0.000208	0.0012	CcSEcCtD
Dronedarone—Skin disorder—Paclitaxel—lung cancer	0.000206	0.00119	CcSEcCtD
Dronedarone—Abdominal pain—Irinotecan—lung cancer	0.000205	0.00118	CcSEcCtD
Dronedarone—Pneumonia—Methotrexate—lung cancer	0.000204	0.00118	CcSEcCtD
Dronedarone—Gastrointestinal disorder—Cisplatin—lung cancer	0.000204	0.00117	CcSEcCtD
Dronedarone—Vomiting—Vinorelbine—lung cancer	0.0002	0.00116	CcSEcCtD
Dronedarone—Rash—Vinorelbine—lung cancer	0.000199	0.00115	CcSEcCtD
Dronedarone—Dermatitis—Vinorelbine—lung cancer	0.000199	0.00114	CcSEcCtD
Dronedarone—Hepatobiliary disease—Methotrexate—lung cancer	0.000192	0.00111	CcSEcCtD
Dronedarone—Nausea—Vinorelbine—lung cancer	0.000187	0.00108	CcSEcCtD
Dronedarone—Gastrointestinal disorder—Etoposide—lung cancer	0.000187	0.00108	CcSEcCtD
Dronedarone—Dyspepsia—Paclitaxel—lung cancer	0.000187	0.00108	CcSEcCtD
Dronedarone—Asthenia—Irinotecan—lung cancer	0.000187	0.00108	CcSEcCtD
Dronedarone—Fatigue—Etoposide—lung cancer	0.000186	0.00107	CcSEcCtD
Dronedarone—Unspecified disorder of skin and subcutaneous tissue—Docetaxel—lung cancer	0.000186	0.00107	CcSEcCtD
Dronedarone—ADRA2A—lymph node—lung cancer	0.000184	0.00475	CbGeAlD
Dronedarone—Gastrointestinal disorder—Paclitaxel—lung cancer	0.000183	0.00106	CcSEcCtD
Dronedarone—Fatigue—Paclitaxel—lung cancer	0.000183	0.00105	CcSEcCtD
Dronedarone—Asthenia—Gemcitabine—lung cancer	0.000182	0.00105	CcSEcCtD
Dronedarone—Photosensitivity reaction—Doxorubicin—lung cancer	0.00018	0.00104	CcSEcCtD
Dronedarone—Anaphylactic shock—Docetaxel—lung cancer	0.00018	0.00104	CcSEcCtD
Dronedarone—Pruritus—Gemcitabine—lung cancer	0.000179	0.00103	CcSEcCtD
Dronedarone—Diarrhoea—Irinotecan—lung cancer	0.000178	0.00103	CcSEcCtD
Dronedarone—Pneumonia—Doxorubicin—lung cancer	0.000177	0.00102	CcSEcCtD
Dronedarone—Gastrointestinal pain—Etoposide—lung cancer	0.000177	0.00102	CcSEcCtD
Dronedarone—Nervous system disorder—Docetaxel—lung cancer	0.000176	0.00102	CcSEcCtD
Dronedarone—Skin disorder—Docetaxel—lung cancer	0.000175	0.00101	CcSEcCtD
Dronedarone—Gastrointestinal pain—Paclitaxel—lung cancer	0.000173	0.000999	CcSEcCtD
Dronedarone—Diarrhoea—Gemcitabine—lung cancer	0.000173	0.000999	CcSEcCtD
Dronedarone—Abdominal pain—Etoposide—lung cancer	0.000171	0.000985	CcSEcCtD
Dronedarone—Asthenia—Cisplatin—lung cancer	0.000169	0.000976	CcSEcCtD
Dronedarone—Cardiac disorder—Methotrexate—lung cancer	0.000169	0.000975	CcSEcCtD
Dronedarone—Abdominal pain—Paclitaxel—lung cancer	0.000168	0.000966	CcSEcCtD
Dronedarone—Hepatobiliary disease—Doxorubicin—lung cancer	0.000166	0.000959	CcSEcCtD
Dronedarone—ABCB1—bone marrow—lung cancer	0.000166	0.00427	CbGeAlD
Dronedarone—Angiopathy—Methotrexate—lung cancer	0.000165	0.000954	CcSEcCtD
Dronedarone—Vomiting—Irinotecan—lung cancer	0.000165	0.000953	CcSEcCtD
Dronedarone—Immune system disorder—Methotrexate—lung cancer	0.000165	0.000949	CcSEcCtD
Dronedarone—Mediastinal disorder—Methotrexate—lung cancer	0.000164	0.000947	CcSEcCtD
Dronedarone—Rash—Irinotecan—lung cancer	0.000164	0.000945	CcSEcCtD
Dronedarone—Dermatitis—Irinotecan—lung cancer	0.000164	0.000944	CcSEcCtD
Dronedarone—Diarrhoea—Cisplatin—lung cancer	0.000161	0.000931	CcSEcCtD
Dronedarone—Vomiting—Gemcitabine—lung cancer	0.000161	0.000928	CcSEcCtD
Dronedarone—Bradycardia—Doxorubicin—lung cancer	0.000161	0.000926	CcSEcCtD
Dronedarone—Rash—Gemcitabine—lung cancer	0.00016	0.00092	CcSEcCtD
Dronedarone—Dermatitis—Gemcitabine—lung cancer	0.00016	0.00092	CcSEcCtD
Dronedarone—Erythema—Methotrexate—lung cancer	0.000159	0.000915	CcSEcCtD
Dronedarone—Dyspepsia—Docetaxel—lung cancer	0.000158	0.000912	CcSEcCtD
Dronedarone—Dysgeusia—Methotrexate—lung cancer	0.000155	0.000896	CcSEcCtD
Dronedarone—Gastrointestinal disorder—Docetaxel—lung cancer	0.000155	0.000894	CcSEcCtD
Dronedarone—Asthenia—Etoposide—lung cancer	0.000155	0.000894	CcSEcCtD
Dronedarone—Fatigue—Docetaxel—lung cancer	0.000155	0.000893	CcSEcCtD
Dronedarone—Nausea—Irinotecan—lung cancer	0.000154	0.00089	CcSEcCtD
Dronedarone—Pruritus—Etoposide—lung cancer	0.000153	0.000882	CcSEcCtD
Dronedarone—Asthenia—Paclitaxel—lung cancer	0.000152	0.000877	CcSEcCtD
Dronedarone—Nausea—Gemcitabine—lung cancer	0.00015	0.000867	CcSEcCtD
Dronedarone—Vomiting—Cisplatin—lung cancer	0.00015	0.000865	CcSEcCtD
Dronedarone—ABCB1—lung—lung cancer	0.00015	0.00387	CbGeAlD
Dronedarone—Pruritus—Paclitaxel—lung cancer	0.00015	0.000865	CcSEcCtD
Dronedarone—Rash—Cisplatin—lung cancer	0.000149	0.000858	CcSEcCtD
Dronedarone—Dermatitis—Cisplatin—lung cancer	0.000149	0.000857	CcSEcCtD
Dronedarone—Diarrhoea—Etoposide—lung cancer	0.000148	0.000853	CcSEcCtD
Dronedarone—Gastrointestinal pain—Docetaxel—lung cancer	0.000147	0.000847	CcSEcCtD
Dronedarone—Cardiac disorder—Doxorubicin—lung cancer	0.000147	0.000845	CcSEcCtD
Dronedarone—Diarrhoea—Paclitaxel—lung cancer	0.000145	0.000836	CcSEcCtD
Dronedarone—Angiopathy—Doxorubicin—lung cancer	0.000143	0.000826	CcSEcCtD
Dronedarone—Immune system disorder—Doxorubicin—lung cancer	0.000143	0.000822	CcSEcCtD
Dronedarone—Mediastinal disorder—Doxorubicin—lung cancer	0.000142	0.00082	CcSEcCtD
Dronedarone—Abdominal pain—Docetaxel—lung cancer	0.000142	0.000819	CcSEcCtD
Dronedarone—Nausea—Cisplatin—lung cancer	0.00014	0.000808	CcSEcCtD
Dronedarone—Vomiting—Etoposide—lung cancer	0.000137	0.000793	CcSEcCtD
Dronedarone—Erythema—Doxorubicin—lung cancer	0.000137	0.000792	CcSEcCtD
Dronedarone—Rash—Etoposide—lung cancer	0.000136	0.000786	CcSEcCtD
Dronedarone—Dermatitis—Etoposide—lung cancer	0.000136	0.000785	CcSEcCtD
Dronedarone—Vomiting—Paclitaxel—lung cancer	0.000135	0.000777	CcSEcCtD
Dronedarone—Dysgeusia—Doxorubicin—lung cancer	0.000135	0.000776	CcSEcCtD
Dronedarone—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—lung cancer	0.000134	0.000774	CcSEcCtD
Dronedarone—Rash—Paclitaxel—lung cancer	0.000134	0.000771	CcSEcCtD
Dronedarone—Dermatitis—Paclitaxel—lung cancer	0.000134	0.00077	CcSEcCtD
Dronedarone—Anaphylactic shock—Methotrexate—lung cancer	0.00013	0.000747	CcSEcCtD
Dronedarone—Asthenia—Docetaxel—lung cancer	0.000129	0.000743	CcSEcCtD
Dronedarone—Nausea—Etoposide—lung cancer	0.000128	0.00074	CcSEcCtD
Dronedarone—Pruritus—Docetaxel—lung cancer	0.000127	0.000733	CcSEcCtD
Dronedarone—Nervous system disorder—Methotrexate—lung cancer	0.000127	0.000732	CcSEcCtD
Dronedarone—Nausea—Paclitaxel—lung cancer	0.000126	0.000726	CcSEcCtD
Dronedarone—Skin disorder—Methotrexate—lung cancer	0.000126	0.000725	CcSEcCtD
Dronedarone—Diarrhoea—Docetaxel—lung cancer	0.000123	0.000709	CcSEcCtD
Dronedarone—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—lung cancer	0.000116	0.00067	CcSEcCtD
Dronedarone—Vomiting—Docetaxel—lung cancer	0.000114	0.000659	CcSEcCtD
Dronedarone—Dyspepsia—Methotrexate—lung cancer	0.000114	0.000657	CcSEcCtD
Dronedarone—Rash—Docetaxel—lung cancer	0.000113	0.000653	CcSEcCtD
Dronedarone—Dermatitis—Docetaxel—lung cancer	0.000113	0.000653	CcSEcCtD
Dronedarone—Anaphylactic shock—Doxorubicin—lung cancer	0.000112	0.000647	CcSEcCtD
Dronedarone—Gastrointestinal disorder—Methotrexate—lung cancer	0.000112	0.000645	CcSEcCtD
Dronedarone—Fatigue—Methotrexate—lung cancer	0.000112	0.000644	CcSEcCtD
Dronedarone—Nervous system disorder—Doxorubicin—lung cancer	0.00011	0.000634	CcSEcCtD
Dronedarone—Skin disorder—Doxorubicin—lung cancer	0.000109	0.000628	CcSEcCtD
Dronedarone—Nausea—Docetaxel—lung cancer	0.000107	0.000615	CcSEcCtD
Dronedarone—Gastrointestinal pain—Methotrexate—lung cancer	0.000106	0.000611	CcSEcCtD
Dronedarone—ABCB1—lymph node—lung cancer	0.000103	0.00264	CbGeAlD
Dronedarone—Abdominal pain—Methotrexate—lung cancer	0.000102	0.00059	CcSEcCtD
Dronedarone—Dyspepsia—Doxorubicin—lung cancer	9.87e-05	0.000569	CcSEcCtD
Dronedarone—Gastrointestinal disorder—Doxorubicin—lung cancer	9.68e-05	0.000558	CcSEcCtD
Dronedarone—Fatigue—Doxorubicin—lung cancer	9.67e-05	0.000557	CcSEcCtD
Dronedarone—Asthenia—Methotrexate—lung cancer	9.29e-05	0.000536	CcSEcCtD
Dronedarone—Gastrointestinal pain—Doxorubicin—lung cancer	9.17e-05	0.000529	CcSEcCtD
Dronedarone—Pruritus—Methotrexate—lung cancer	9.16e-05	0.000528	CcSEcCtD
Dronedarone—Abdominal pain—Doxorubicin—lung cancer	8.87e-05	0.000511	CcSEcCtD
Dronedarone—Diarrhoea—Methotrexate—lung cancer	8.86e-05	0.000511	CcSEcCtD
Dronedarone—Vomiting—Methotrexate—lung cancer	8.23e-05	0.000475	CcSEcCtD
Dronedarone—Rash—Methotrexate—lung cancer	8.17e-05	0.000471	CcSEcCtD
Dronedarone—Dermatitis—Methotrexate—lung cancer	8.16e-05	0.00047	CcSEcCtD
Dronedarone—Asthenia—Doxorubicin—lung cancer	8.05e-05	0.000464	CcSEcCtD
Dronedarone—Pruritus—Doxorubicin—lung cancer	7.93e-05	0.000457	CcSEcCtD
Dronedarone—Nausea—Methotrexate—lung cancer	7.69e-05	0.000444	CcSEcCtD
Dronedarone—Diarrhoea—Doxorubicin—lung cancer	7.67e-05	0.000442	CcSEcCtD
Dronedarone—Vomiting—Doxorubicin—lung cancer	7.13e-05	0.000411	CcSEcCtD
Dronedarone—Rash—Doxorubicin—lung cancer	7.07e-05	0.000408	CcSEcCtD
Dronedarone—Dermatitis—Doxorubicin—lung cancer	7.06e-05	0.000407	CcSEcCtD
Dronedarone—Nausea—Doxorubicin—lung cancer	6.66e-05	0.000384	CcSEcCtD
Dronedarone—ADRB1—Signaling Pathways—IL2—lung cancer	2.93e-06	1.84e-05	CbGpPWpGaD
Dronedarone—ADRB1—Signaling by GPCR—IL6—lung cancer	2.91e-06	1.83e-05	CbGpPWpGaD
Dronedarone—ADRA2C—Metabolism—EP300—lung cancer	2.91e-06	1.83e-05	CbGpPWpGaD
Dronedarone—ADRA2B—Signaling Pathways—CASP3—lung cancer	2.91e-06	1.82e-05	CbGpPWpGaD
Dronedarone—ADRA2A—Signaling Pathways—IL6R—lung cancer	2.91e-06	1.82e-05	CbGpPWpGaD
Dronedarone—ADRA1B—Signaling Pathways—PIK3CB—lung cancer	2.91e-06	1.82e-05	CbGpPWpGaD
Dronedarone—ADRA1B—Signaling Pathways—MTOR—lung cancer	2.91e-06	1.82e-05	CbGpPWpGaD
Dronedarone—ADRA2B—Signaling Pathways—IL2—lung cancer	2.9e-06	1.82e-05	CbGpPWpGaD
Dronedarone—ADRA2A—Signaling Pathways—CREBBP—lung cancer	2.9e-06	1.82e-05	CbGpPWpGaD
Dronedarone—ADRA1A—Signaling by GPCR—KRAS—lung cancer	2.9e-06	1.82e-05	CbGpPWpGaD
Dronedarone—ADRA2B—Signaling by GPCR—IL6—lung cancer	2.89e-06	1.81e-05	CbGpPWpGaD
Dronedarone—ADRA1D—Signaling Pathways—EP300—lung cancer	2.88e-06	1.81e-05	CbGpPWpGaD
Dronedarone—ADRA2A—Metabolism—PIK3CB—lung cancer	2.87e-06	1.8e-05	CbGpPWpGaD
Dronedarone—ADRB1—Signaling Pathways—CCND1—lung cancer	2.86e-06	1.79e-05	CbGpPWpGaD
Dronedarone—ADRA2A—Signaling by GPCR—EGFR—lung cancer	2.85e-06	1.79e-05	CbGpPWpGaD
Dronedarone—ADRB1—Signaling Pathways—JUN—lung cancer	2.85e-06	1.79e-05	CbGpPWpGaD
Dronedarone—ADRA2A—Metabolism—PTGS2—lung cancer	2.84e-06	1.78e-05	CbGpPWpGaD
Dronedarone—ADRA2C—Signaling Pathways—CXCL8—lung cancer	2.84e-06	1.78e-05	CbGpPWpGaD
Dronedarone—ABCB1—Metabolism—APOA1—lung cancer	2.83e-06	1.78e-05	CbGpPWpGaD
Dronedarone—CYP3A4—Metabolism—CYP2E1—lung cancer	2.83e-06	1.78e-05	CbGpPWpGaD
Dronedarone—ADRA2B—Signaling Pathways—CCND1—lung cancer	2.83e-06	1.78e-05	CbGpPWpGaD
Dronedarone—ADRA2B—Signaling Pathways—JUN—lung cancer	2.82e-06	1.77e-05	CbGpPWpGaD
Dronedarone—ADRA2C—Signaling by GPCR—HRAS—lung cancer	2.82e-06	1.77e-05	CbGpPWpGaD
Dronedarone—ALB—Metabolism—POMC—lung cancer	2.81e-06	1.76e-05	CbGpPWpGaD
Dronedarone—ADRA1D—Signaling Pathways—SRC—lung cancer	2.81e-06	1.76e-05	CbGpPWpGaD
Dronedarone—CYP3A4—Metabolism—NQO1—lung cancer	2.8e-06	1.76e-05	CbGpPWpGaD
Dronedarone—ADRA1B—Signaling Pathways—CXCL8—lung cancer	2.79e-06	1.75e-05	CbGpPWpGaD
Dronedarone—ALB—Hemostasis—AKT1—lung cancer	2.78e-06	1.74e-05	CbGpPWpGaD
Dronedarone—ADRA1B—Signaling by GPCR—HRAS—lung cancer	2.77e-06	1.74e-05	CbGpPWpGaD
Dronedarone—ADRB1—Signaling Pathways—MMP9—lung cancer	2.77e-06	1.74e-05	CbGpPWpGaD
Dronedarone—ADRA2A—Signaling Pathways—MAP2K1—lung cancer	2.77e-06	1.74e-05	CbGpPWpGaD
Dronedarone—ADRB1—Signaling Pathways—CDKN1A—lung cancer	2.76e-06	1.73e-05	CbGpPWpGaD
Dronedarone—ADRB1—Signaling Pathways—PTEN—lung cancer	2.76e-06	1.73e-05	CbGpPWpGaD
Dronedarone—ADRA2A—Signaling Pathways—PIK3CD—lung cancer	2.75e-06	1.73e-05	CbGpPWpGaD
Dronedarone—ADRA2B—Signaling Pathways—MMP9—lung cancer	2.75e-06	1.72e-05	CbGpPWpGaD
Dronedarone—ADRA2C—GPCR downstream signaling—AKT1—lung cancer	2.74e-06	1.72e-05	CbGpPWpGaD
Dronedarone—ALB—Metabolism—CREBBP—lung cancer	2.74e-06	1.72e-05	CbGpPWpGaD
Dronedarone—ADRA2B—Signaling Pathways—CDKN1A—lung cancer	2.74e-06	1.72e-05	CbGpPWpGaD
Dronedarone—ADRA1D—Signaling Pathways—VEGFA—lung cancer	2.73e-06	1.71e-05	CbGpPWpGaD
Dronedarone—ADRA2B—Signaling Pathways—PTEN—lung cancer	2.73e-06	1.71e-05	CbGpPWpGaD
Dronedarone—ADRA2A—GPCR downstream signaling—PIK3CA—lung cancer	2.73e-06	1.71e-05	CbGpPWpGaD
Dronedarone—ADRA2C—Signaling Pathways—CASP3—lung cancer	2.72e-06	1.7e-05	CbGpPWpGaD
Dronedarone—ADRA2C—Signaling Pathways—IL2—lung cancer	2.71e-06	1.7e-05	CbGpPWpGaD
Dronedarone—ADRA1D—Signaling Pathways—STAT3—lung cancer	2.71e-06	1.7e-05	CbGpPWpGaD
Dronedarone—ADRA1D—Signaling Pathways—NRAS—lung cancer	2.7e-06	1.69e-05	CbGpPWpGaD
Dronedarone—ADRA2C—Signaling by GPCR—IL6—lung cancer	2.7e-06	1.69e-05	CbGpPWpGaD
Dronedarone—ADRA1B—GPCR downstream signaling—AKT1—lung cancer	2.7e-06	1.69e-05	CbGpPWpGaD
Dronedarone—ADRA2A—Signaling by GPCR—KRAS—lung cancer	2.69e-06	1.69e-05	CbGpPWpGaD
Dronedarone—ADRB1—Signaling by GPCR—AKT1—lung cancer	2.69e-06	1.69e-05	CbGpPWpGaD
Dronedarone—ADRA1B—Signaling Pathways—CASP3—lung cancer	2.67e-06	1.68e-05	CbGpPWpGaD
Dronedarone—CYP2D6—Metabolism—APOA1—lung cancer	2.67e-06	1.68e-05	CbGpPWpGaD
Dronedarone—ADRA1B—Signaling Pathways—IL2—lung cancer	2.67e-06	1.67e-05	CbGpPWpGaD
Dronedarone—ADRA2B—Signaling by GPCR—AKT1—lung cancer	2.66e-06	1.67e-05	CbGpPWpGaD
Dronedarone—ADRA1A—Signaling by GPCR—PIK3CA—lung cancer	2.66e-06	1.67e-05	CbGpPWpGaD
Dronedarone—ADRA1B—Signaling by GPCR—IL6—lung cancer	2.66e-06	1.67e-05	CbGpPWpGaD
Dronedarone—ADRA1A—Signaling Pathways—MDM2—lung cancer	2.65e-06	1.66e-05	CbGpPWpGaD
Dronedarone—ADRA1A—Signaling Pathways—RAF1—lung cancer	2.64e-06	1.66e-05	CbGpPWpGaD
Dronedarone—ADRA2C—Signaling Pathways—CCND1—lung cancer	2.64e-06	1.66e-05	CbGpPWpGaD
Dronedarone—ADRA2C—Signaling Pathways—JUN—lung cancer	2.64e-06	1.65e-05	CbGpPWpGaD
Dronedarone—ADRB1—Signaling Pathways—EP300—lung cancer	2.63e-06	1.65e-05	CbGpPWpGaD
Dronedarone—ADRA1A—Signaling Pathways—ERBB2—lung cancer	2.62e-06	1.64e-05	CbGpPWpGaD
Dronedarone—ADRA2B—Signaling Pathways—EP300—lung cancer	2.6e-06	1.63e-05	CbGpPWpGaD
Dronedarone—ADRA1B—Signaling Pathways—CCND1—lung cancer	2.6e-06	1.63e-05	CbGpPWpGaD
Dronedarone—ALB—Metabolism—PIK3CD—lung cancer	2.6e-06	1.63e-05	CbGpPWpGaD
Dronedarone—ADRA1B—Signaling Pathways—JUN—lung cancer	2.6e-06	1.63e-05	CbGpPWpGaD
Dronedarone—ABCB1—Metabolism—PIK3CG—lung cancer	2.59e-06	1.62e-05	CbGpPWpGaD
Dronedarone—ADRA1D—Signaling Pathways—MAPK3—lung cancer	2.58e-06	1.62e-05	CbGpPWpGaD
Dronedarone—ADRA1A—Signaling Pathways—MTOR—lung cancer	2.58e-06	1.62e-05	CbGpPWpGaD
Dronedarone—ADRA1A—Signaling Pathways—PIK3CB—lung cancer	2.58e-06	1.62e-05	CbGpPWpGaD
Dronedarone—ADRA2C—Signaling Pathways—MMP9—lung cancer	2.57e-06	1.61e-05	CbGpPWpGaD
Dronedarone—ADRA2C—Signaling Pathways—CDKN1A—lung cancer	2.56e-06	1.6e-05	CbGpPWpGaD
Dronedarone—ADRB1—Signaling Pathways—SRC—lung cancer	2.56e-06	1.6e-05	CbGpPWpGaD
Dronedarone—ADRA2C—Signaling Pathways—PTEN—lung cancer	2.55e-06	1.6e-05	CbGpPWpGaD
Dronedarone—ADRA2B—Signaling Pathways—SRC—lung cancer	2.53e-06	1.59e-05	CbGpPWpGaD
Dronedarone—ADRA1B—Signaling Pathways—MMP9—lung cancer	2.53e-06	1.58e-05	CbGpPWpGaD
Dronedarone—CYP3A4—Metabolism—STK11—lung cancer	2.53e-06	1.58e-05	CbGpPWpGaD
Dronedarone—ADRA1B—Signaling Pathways—CDKN1A—lung cancer	2.52e-06	1.58e-05	CbGpPWpGaD
Dronedarone—ADRA1D—Signaling Pathways—MYC—lung cancer	2.51e-06	1.58e-05	CbGpPWpGaD
Dronedarone—ADRA1B—Signaling Pathways—PTEN—lung cancer	2.51e-06	1.58e-05	CbGpPWpGaD
Dronedarone—ADRB1—Signaling Pathways—VEGFA—lung cancer	2.49e-06	1.56e-05	CbGpPWpGaD
Dronedarone—ADRA2C—Signaling by GPCR—AKT1—lung cancer	2.49e-06	1.56e-05	CbGpPWpGaD
Dronedarone—ADRA1A—Signaling Pathways—CXCL8—lung cancer	2.48e-06	1.56e-05	CbGpPWpGaD
Dronedarone—ADRA2A—Metabolism—PTEN—lung cancer	2.48e-06	1.55e-05	CbGpPWpGaD
Dronedarone—ADRA2A—Signaling by GPCR—PIK3CA—lung cancer	2.47e-06	1.55e-05	CbGpPWpGaD
Dronedarone—ADRA2B—Signaling Pathways—VEGFA—lung cancer	2.47e-06	1.55e-05	CbGpPWpGaD
Dronedarone—ADRB1—Signaling Pathways—STAT3—lung cancer	2.47e-06	1.55e-05	CbGpPWpGaD
Dronedarone—ADRA2A—Signaling Pathways—MDM2—lung cancer	2.46e-06	1.55e-05	CbGpPWpGaD
Dronedarone—ADRA1A—Signaling by GPCR—HRAS—lung cancer	2.46e-06	1.55e-05	CbGpPWpGaD
Dronedarone—ABCB1—Metabolism—POMC—lung cancer	2.46e-06	1.55e-05	CbGpPWpGaD
Dronedarone—ADRB1—Signaling Pathways—NRAS—lung cancer	2.46e-06	1.54e-05	CbGpPWpGaD
Dronedarone—ADRA1D—Signaling Pathways—EGFR—lung cancer	2.46e-06	1.54e-05	CbGpPWpGaD
Dronedarone—ADRA2A—Signaling Pathways—RAF1—lung cancer	2.46e-06	1.54e-05	CbGpPWpGaD
Dronedarone—ADRA1B—Signaling by GPCR—AKT1—lung cancer	2.45e-06	1.54e-05	CbGpPWpGaD
Dronedarone—ADRA2B—Signaling Pathways—STAT3—lung cancer	2.44e-06	1.53e-05	CbGpPWpGaD
Dronedarone—CYP2D6—Metabolism—PIK3CG—lung cancer	2.44e-06	1.53e-05	CbGpPWpGaD
Dronedarone—ADRA2B—Signaling Pathways—NRAS—lung cancer	2.44e-06	1.53e-05	CbGpPWpGaD
Dronedarone—ADRA2C—Signaling Pathways—EP300—lung cancer	2.43e-06	1.53e-05	CbGpPWpGaD
Dronedarone—ADRA2A—Signaling Pathways—ERBB2—lung cancer	2.43e-06	1.52e-05	CbGpPWpGaD
Dronedarone—ABCB1—Metabolism—CREBBP—lung cancer	2.4e-06	1.51e-05	CbGpPWpGaD
Dronedarone—ADRA2A—Signaling Pathways—PIK3CB—lung cancer	2.4e-06	1.5e-05	CbGpPWpGaD
Dronedarone—ADRA2A—Signaling Pathways—MTOR—lung cancer	2.4e-06	1.5e-05	CbGpPWpGaD
Dronedarone—ADRA1A—GPCR downstream signaling—AKT1—lung cancer	2.4e-06	1.5e-05	CbGpPWpGaD
Dronedarone—ADRA1B—Signaling Pathways—EP300—lung cancer	2.39e-06	1.5e-05	CbGpPWpGaD
Dronedarone—ADRA1A—Signaling Pathways—CASP3—lung cancer	2.37e-06	1.49e-05	CbGpPWpGaD
Dronedarone—ADRA1A—Signaling Pathways—IL2—lung cancer	2.37e-06	1.49e-05	CbGpPWpGaD
Dronedarone—ADRA2C—Signaling Pathways—SRC—lung cancer	2.37e-06	1.48e-05	CbGpPWpGaD
Dronedarone—ADRA2A—Metabolism—EP300—lung cancer	2.36e-06	1.48e-05	CbGpPWpGaD
Dronedarone—ADRA1A—Signaling by GPCR—IL6—lung cancer	2.36e-06	1.48e-05	CbGpPWpGaD
Dronedarone—ADRB1—Signaling Pathways—MAPK3—lung cancer	2.36e-06	1.48e-05	CbGpPWpGaD
Dronedarone—CYP3A4—Metabolism—GSTP1—lung cancer	2.34e-06	1.47e-05	CbGpPWpGaD
Dronedarone—ADRA2B—Signaling Pathways—MAPK3—lung cancer	2.33e-06	1.46e-05	CbGpPWpGaD
Dronedarone—ADRA1B—Signaling Pathways—SRC—lung cancer	2.33e-06	1.46e-05	CbGpPWpGaD
Dronedarone—ADRA1D—Signaling Pathways—KRAS—lung cancer	2.32e-06	1.46e-05	CbGpPWpGaD
Dronedarone—CYP2D6—Metabolism—POMC—lung cancer	2.32e-06	1.46e-05	CbGpPWpGaD
Dronedarone—ADRA1A—Signaling Pathways—CCND1—lung cancer	2.31e-06	1.45e-05	CbGpPWpGaD
Dronedarone—ADRA1A—Signaling Pathways—JUN—lung cancer	2.31e-06	1.45e-05	CbGpPWpGaD
Dronedarone—ADRA2A—Signaling Pathways—CXCL8—lung cancer	2.3e-06	1.45e-05	CbGpPWpGaD
Dronedarone—ADRA2C—Signaling Pathways—VEGFA—lung cancer	2.3e-06	1.45e-05	CbGpPWpGaD
Dronedarone—ADRB1—Signaling Pathways—MYC—lung cancer	2.29e-06	1.44e-05	CbGpPWpGaD
Dronedarone—ADRA2A—Signaling by GPCR—HRAS—lung cancer	2.29e-06	1.44e-05	CbGpPWpGaD
Dronedarone—ADRA2C—Signaling Pathways—STAT3—lung cancer	2.28e-06	1.43e-05	CbGpPWpGaD
Dronedarone—ADRA2C—Signaling Pathways—NRAS—lung cancer	2.28e-06	1.43e-05	CbGpPWpGaD
Dronedarone—ABCB1—Metabolism—PIK3CD—lung cancer	2.28e-06	1.43e-05	CbGpPWpGaD
Dronedarone—CYP3A4—Metabolism—CAT—lung cancer	2.27e-06	1.43e-05	CbGpPWpGaD
Dronedarone—ADRA2B—Signaling Pathways—MYC—lung cancer	2.27e-06	1.42e-05	CbGpPWpGaD
Dronedarone—ADRA1B—Signaling Pathways—VEGFA—lung cancer	2.27e-06	1.42e-05	CbGpPWpGaD
Dronedarone—ALB—Metabolism—PIK3CB—lung cancer	2.26e-06	1.42e-05	CbGpPWpGaD
Dronedarone—CYP2D6—Metabolism—CREBBP—lung cancer	2.26e-06	1.42e-05	CbGpPWpGaD
Dronedarone—ABCB1—Metabolism—ALB—lung cancer	2.25e-06	1.41e-05	CbGpPWpGaD
Dronedarone—ADRA1B—Signaling Pathways—STAT3—lung cancer	2.25e-06	1.41e-05	CbGpPWpGaD
Dronedarone—ADRA1A—Signaling Pathways—MMP9—lung cancer	2.24e-06	1.41e-05	CbGpPWpGaD
Dronedarone—ALB—Metabolism—PTGS2—lung cancer	2.24e-06	1.41e-05	CbGpPWpGaD
Dronedarone—ADRB1—Signaling Pathways—EGFR—lung cancer	2.24e-06	1.41e-05	CbGpPWpGaD
Dronedarone—ADRA1B—Signaling Pathways—NRAS—lung cancer	2.24e-06	1.41e-05	CbGpPWpGaD
Dronedarone—ADRA1A—Signaling Pathways—CDKN1A—lung cancer	2.24e-06	1.4e-05	CbGpPWpGaD
Dronedarone—ADRA1A—Signaling Pathways—PTEN—lung cancer	2.23e-06	1.4e-05	CbGpPWpGaD
Dronedarone—ADRA2A—GPCR downstream signaling—AKT1—lung cancer	2.23e-06	1.4e-05	CbGpPWpGaD
Dronedarone—ADRA2B—Signaling Pathways—EGFR—lung cancer	2.22e-06	1.39e-05	CbGpPWpGaD
Dronedarone—CYP3A4—Metabolism—ABCB1—lung cancer	2.21e-06	1.39e-05	CbGpPWpGaD
Dronedarone—ADRA2A—Signaling Pathways—CASP3—lung cancer	2.21e-06	1.38e-05	CbGpPWpGaD
Dronedarone—ADRA2A—Signaling Pathways—IL2—lung cancer	2.2e-06	1.38e-05	CbGpPWpGaD
Dronedarone—ADRA2A—Signaling by GPCR—IL6—lung cancer	2.19e-06	1.37e-05	CbGpPWpGaD
Dronedarone—ADRA2C—Signaling Pathways—MAPK3—lung cancer	2.18e-06	1.37e-05	CbGpPWpGaD
Dronedarone—ADRA1A—Signaling by GPCR—AKT1—lung cancer	2.18e-06	1.37e-05	CbGpPWpGaD
Dronedarone—CYP3A4—Metabolism—TYMS—lung cancer	2.17e-06	1.36e-05	CbGpPWpGaD
Dronedarone—ADRA2C—Metabolism—PIK3CA—lung cancer	2.15e-06	1.35e-05	CbGpPWpGaD
Dronedarone—CYP3A4—Metabolism—GSTM1—lung cancer	2.15e-06	1.35e-05	CbGpPWpGaD
Dronedarone—ADRA2A—Signaling Pathways—CCND1—lung cancer	2.15e-06	1.35e-05	CbGpPWpGaD
Dronedarone—ADRA1B—Signaling Pathways—MAPK3—lung cancer	2.15e-06	1.35e-05	CbGpPWpGaD
Dronedarone—CYP2D6—Metabolism—PIK3CD—lung cancer	2.14e-06	1.35e-05	CbGpPWpGaD
Dronedarone—ADRA2A—Signaling Pathways—JUN—lung cancer	2.14e-06	1.34e-05	CbGpPWpGaD
Dronedarone—ADRA1D—Signaling Pathways—PIK3CA—lung cancer	2.13e-06	1.34e-05	CbGpPWpGaD
Dronedarone—ADRA1A—Signaling Pathways—EP300—lung cancer	2.13e-06	1.33e-05	CbGpPWpGaD
Dronedarone—ADRA2C—Signaling Pathways—MYC—lung cancer	2.12e-06	1.33e-05	CbGpPWpGaD
Dronedarone—ADRB1—Signaling Pathways—KRAS—lung cancer	2.12e-06	1.33e-05	CbGpPWpGaD
Dronedarone—CYP2D6—Metabolism—ALB—lung cancer	2.12e-06	1.33e-05	CbGpPWpGaD
Dronedarone—ADRA2B—Signaling Pathways—KRAS—lung cancer	2.1e-06	1.32e-05	CbGpPWpGaD
Dronedarone—ADRA1B—Signaling Pathways—MYC—lung cancer	2.09e-06	1.31e-05	CbGpPWpGaD
Dronedarone—ADRA2A—Signaling Pathways—MMP9—lung cancer	2.08e-06	1.31e-05	CbGpPWpGaD
Dronedarone—ADRA2A—Signaling Pathways—CDKN1A—lung cancer	2.08e-06	1.3e-05	CbGpPWpGaD
Dronedarone—ADRA2C—Signaling Pathways—EGFR—lung cancer	2.07e-06	1.3e-05	CbGpPWpGaD
Dronedarone—ADRA2A—Signaling Pathways—PTEN—lung cancer	2.07e-06	1.3e-05	CbGpPWpGaD
Dronedarone—ADRA1A—Signaling Pathways—SRC—lung cancer	2.07e-06	1.3e-05	CbGpPWpGaD
Dronedarone—ADRA1D—Signaling Pathways—TP53—lung cancer	2.06e-06	1.3e-05	CbGpPWpGaD
Dronedarone—ADRA1B—Signaling Pathways—EGFR—lung cancer	2.04e-06	1.28e-05	CbGpPWpGaD
Dronedarone—CYP3A4—Metabolism—CYP1A1—lung cancer	2.04e-06	1.28e-05	CbGpPWpGaD
Dronedarone—ADRA2A—Signaling by GPCR—AKT1—lung cancer	2.02e-06	1.27e-05	CbGpPWpGaD
Dronedarone—CYP3A4—Metabolism—ERCC2—lung cancer	2.02e-06	1.27e-05	CbGpPWpGaD
Dronedarone—ADRA1A—Signaling Pathways—VEGFA—lung cancer	2.01e-06	1.26e-05	CbGpPWpGaD
Dronedarone—ADRA1A—Signaling Pathways—STAT3—lung cancer	1.99e-06	1.25e-05	CbGpPWpGaD
Dronedarone—ADRA1A—Signaling Pathways—NRAS—lung cancer	1.99e-06	1.25e-05	CbGpPWpGaD
Dronedarone—ABCB1—Metabolism—PIK3CB—lung cancer	1.98e-06	1.24e-05	CbGpPWpGaD
Dronedarone—ADRA2A—Signaling Pathways—EP300—lung cancer	1.98e-06	1.24e-05	CbGpPWpGaD
Dronedarone—ADRA1D—Signaling Pathways—HRAS—lung cancer	1.97e-06	1.24e-05	CbGpPWpGaD
Dronedarone—ABCB1—Metabolism—PTGS2—lung cancer	1.96e-06	1.23e-05	CbGpPWpGaD
Dronedarone—ADRA2C—Signaling Pathways—KRAS—lung cancer	1.96e-06	1.23e-05	CbGpPWpGaD
Dronedarone—ALB—Metabolism—PTEN—lung cancer	1.96e-06	1.23e-05	CbGpPWpGaD
Dronedarone—ADRB1—Signaling Pathways—PIK3CA—lung cancer	1.94e-06	1.22e-05	CbGpPWpGaD
Dronedarone—ADRA1B—Signaling Pathways—KRAS—lung cancer	1.93e-06	1.21e-05	CbGpPWpGaD
Dronedarone—ADRA2B—Signaling Pathways—PIK3CA—lung cancer	1.93e-06	1.21e-05	CbGpPWpGaD
Dronedarone—ADRA2A—Signaling Pathways—SRC—lung cancer	1.92e-06	1.21e-05	CbGpPWpGaD
Dronedarone—ADRA1A—Signaling Pathways—MAPK3—lung cancer	1.91e-06	1.2e-05	CbGpPWpGaD
Dronedarone—ADRA1D—Signaling Pathways—IL6—lung cancer	1.89e-06	1.19e-05	CbGpPWpGaD
Dronedarone—ADRB1—Signaling Pathways—TP53—lung cancer	1.88e-06	1.18e-05	CbGpPWpGaD
Dronedarone—ADRA2A—Signaling Pathways—VEGFA—lung cancer	1.87e-06	1.17e-05	CbGpPWpGaD
Dronedarone—CYP2D6—Metabolism—PIK3CB—lung cancer	1.87e-06	1.17e-05	CbGpPWpGaD
Dronedarone—ALB—Metabolism—EP300—lung cancer	1.87e-06	1.17e-05	CbGpPWpGaD
Dronedarone—ADRA2B—Signaling Pathways—TP53—lung cancer	1.86e-06	1.17e-05	CbGpPWpGaD
Dronedarone—ADRA1A—Signaling Pathways—MYC—lung cancer	1.85e-06	1.16e-05	CbGpPWpGaD
Dronedarone—ADRA2A—Signaling Pathways—STAT3—lung cancer	1.85e-06	1.16e-05	CbGpPWpGaD
Dronedarone—CYP2D6—Metabolism—PTGS2—lung cancer	1.85e-06	1.16e-05	CbGpPWpGaD
Dronedarone—ADRA2A—Signaling Pathways—NRAS—lung cancer	1.85e-06	1.16e-05	CbGpPWpGaD
Dronedarone—ADRA1A—Signaling Pathways—EGFR—lung cancer	1.81e-06	1.14e-05	CbGpPWpGaD
Dronedarone—ADRA2C—Signaling Pathways—PIK3CA—lung cancer	1.8e-06	1.13e-05	CbGpPWpGaD
Dronedarone—ADRB1—Signaling Pathways—HRAS—lung cancer	1.8e-06	1.13e-05	CbGpPWpGaD
Dronedarone—ADRA2B—Signaling Pathways—HRAS—lung cancer	1.78e-06	1.12e-05	CbGpPWpGaD
Dronedarone—ADRA1B—Signaling Pathways—PIK3CA—lung cancer	1.77e-06	1.11e-05	CbGpPWpGaD
Dronedarone—ADRA2A—Signaling Pathways—MAPK3—lung cancer	1.77e-06	1.11e-05	CbGpPWpGaD
Dronedarone—ADRA2C—Metabolism—AKT1—lung cancer	1.76e-06	1.1e-05	CbGpPWpGaD
Dronedarone—ADRA2A—Metabolism—PIK3CA—lung cancer	1.75e-06	1.1e-05	CbGpPWpGaD
Dronedarone—CYP3A4—Metabolism—APOA1—lung cancer	1.75e-06	1.1e-05	CbGpPWpGaD
Dronedarone—ADRA1D—Signaling Pathways—AKT1—lung cancer	1.74e-06	1.09e-05	CbGpPWpGaD
Dronedarone—ADRA2C—Signaling Pathways—TP53—lung cancer	1.74e-06	1.09e-05	CbGpPWpGaD
Dronedarone—ADRA2A—Signaling Pathways—MYC—lung cancer	1.72e-06	1.08e-05	CbGpPWpGaD
Dronedarone—ADRB1—Signaling Pathways—IL6—lung cancer	1.72e-06	1.08e-05	CbGpPWpGaD
Dronedarone—ABCB1—Metabolism—PTEN—lung cancer	1.71e-06	1.08e-05	CbGpPWpGaD
Dronedarone—ADRA1B—Signaling Pathways—TP53—lung cancer	1.71e-06	1.08e-05	CbGpPWpGaD
Dronedarone—ADRA1A—Signaling Pathways—KRAS—lung cancer	1.71e-06	1.07e-05	CbGpPWpGaD
Dronedarone—ADRA2B—Signaling Pathways—IL6—lung cancer	1.71e-06	1.07e-05	CbGpPWpGaD
Dronedarone—ADRA2A—Signaling Pathways—EGFR—lung cancer	1.68e-06	1.06e-05	CbGpPWpGaD
Dronedarone—ADRA2C—Signaling Pathways—HRAS—lung cancer	1.67e-06	1.04e-05	CbGpPWpGaD
Dronedarone—ADRA1B—Signaling Pathways—HRAS—lung cancer	1.64e-06	1.03e-05	CbGpPWpGaD
Dronedarone—ABCB1—Metabolism—EP300—lung cancer	1.63e-06	1.03e-05	CbGpPWpGaD
Dronedarone—CYP2D6—Metabolism—PTEN—lung cancer	1.61e-06	1.01e-05	CbGpPWpGaD
Dronedarone—CYP3A4—Metabolism—PIK3CG—lung cancer	1.59e-06	1e-05	CbGpPWpGaD
Dronedarone—ADRA2C—Signaling Pathways—IL6—lung cancer	1.59e-06	1e-05	CbGpPWpGaD
Dronedarone—ADRA2A—Signaling Pathways—KRAS—lung cancer	1.59e-06	9.98e-06	CbGpPWpGaD
Dronedarone—ADRB1—Signaling Pathways—AKT1—lung cancer	1.59e-06	9.97e-06	CbGpPWpGaD
Dronedarone—ADRA2B—Signaling Pathways—AKT1—lung cancer	1.57e-06	9.88e-06	CbGpPWpGaD
Dronedarone—ADRA1A—Signaling Pathways—PIK3CA—lung cancer	1.57e-06	9.87e-06	CbGpPWpGaD
Dronedarone—ADRA1B—Signaling Pathways—IL6—lung cancer	1.57e-06	9.84e-06	CbGpPWpGaD
Dronedarone—CYP2D6—Metabolism—EP300—lung cancer	1.54e-06	9.66e-06	CbGpPWpGaD
Dronedarone—ADRA1A—Signaling Pathways—TP53—lung cancer	1.52e-06	9.55e-06	CbGpPWpGaD
Dronedarone—CYP3A4—Metabolism—POMC—lung cancer	1.52e-06	9.52e-06	CbGpPWpGaD
Dronedarone—CYP3A4—Metabolism—CREBBP—lung cancer	1.48e-06	9.28e-06	CbGpPWpGaD
Dronedarone—ADRA2C—Signaling Pathways—AKT1—lung cancer	1.47e-06	9.22e-06	CbGpPWpGaD
Dronedarone—ADRA2A—Signaling Pathways—PIK3CA—lung cancer	1.46e-06	9.17e-06	CbGpPWpGaD
Dronedarone—ADRA1A—Signaling Pathways—HRAS—lung cancer	1.46e-06	9.13e-06	CbGpPWpGaD
Dronedarone—ADRA1B—Signaling Pathways—AKT1—lung cancer	1.45e-06	9.08e-06	CbGpPWpGaD
Dronedarone—ADRA2A—Metabolism—AKT1—lung cancer	1.43e-06	8.96e-06	CbGpPWpGaD
Dronedarone—ADRA2A—Signaling Pathways—TP53—lung cancer	1.41e-06	8.87e-06	CbGpPWpGaD
Dronedarone—CYP3A4—Metabolism—PIK3CD—lung cancer	1.4e-06	8.8e-06	CbGpPWpGaD
Dronedarone—ADRA1A—Signaling Pathways—IL6—lung cancer	1.39e-06	8.74e-06	CbGpPWpGaD
Dronedarone—CYP3A4—Metabolism—ALB—lung cancer	1.38e-06	8.68e-06	CbGpPWpGaD
Dronedarone—ALB—Metabolism—PIK3CA—lung cancer	1.38e-06	8.66e-06	CbGpPWpGaD
Dronedarone—ADRA2A—Signaling Pathways—HRAS—lung cancer	1.35e-06	8.49e-06	CbGpPWpGaD
Dronedarone—ADRA2A—Signaling Pathways—IL6—lung cancer	1.29e-06	8.12e-06	CbGpPWpGaD
Dronedarone—ADRA1A—Signaling Pathways—AKT1—lung cancer	1.29e-06	8.06e-06	CbGpPWpGaD
Dronedarone—CYP3A4—Metabolism—PIK3CB—lung cancer	1.22e-06	7.67e-06	CbGpPWpGaD
Dronedarone—CYP3A4—Metabolism—PTGS2—lung cancer	1.21e-06	7.6e-06	CbGpPWpGaD
Dronedarone—ABCB1—Metabolism—PIK3CA—lung cancer	1.21e-06	7.59e-06	CbGpPWpGaD
Dronedarone—ADRA2A—Signaling Pathways—AKT1—lung cancer	1.19e-06	7.49e-06	CbGpPWpGaD
Dronedarone—CYP2D6—Metabolism—PIK3CA—lung cancer	1.14e-06	7.15e-06	CbGpPWpGaD
Dronedarone—ALB—Metabolism—AKT1—lung cancer	1.13e-06	7.07e-06	CbGpPWpGaD
Dronedarone—CYP3A4—Metabolism—PTEN—lung cancer	1.06e-06	6.62e-06	CbGpPWpGaD
Dronedarone—CYP3A4—Metabolism—EP300—lung cancer	1.01e-06	6.32e-06	CbGpPWpGaD
Dronedarone—ABCB1—Metabolism—AKT1—lung cancer	9.88e-07	6.2e-06	CbGpPWpGaD
Dronedarone—CYP2D6—Metabolism—AKT1—lung cancer	9.31e-07	5.84e-06	CbGpPWpGaD
Dronedarone—CYP3A4—Metabolism—PIK3CA—lung cancer	7.45e-07	4.67e-06	CbGpPWpGaD
Dronedarone—CYP3A4—Metabolism—AKT1—lung cancer	6.08e-07	3.82e-06	CbGpPWpGaD
